Related Experiment Video

Updated: Jun 2, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Benefit of stem cells and skeletal myoblast cells in dilated cardiomyopathies

Luiz César Guarita-Souza1, Júlio César Francisco, Rossana Simeoni

  • 1Luiz César Guarita-Souza, Júlio César Francisco, Rossana Simeoni, Jose Rocha Faria-Neto, Department of Post Graduation Surgery, Pontifical Catholic University of Parana, 81200-525 Curitiba Pr, Brazil.

World Journal of Cardiology
|April 20, 2011
PubMed

Insights

Cardiomyocytes lack significant regenerative capacity post-myocardial infarction, leading to heart failure. Cell transplantation shows promise, with bone marrow cells benefiting hibernating myocardium and skeletal myoblasts addressing contractile loss.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Cardiac Pathology

Background:

  • Cardiomyocytes exhibit limited regenerative capacity following myocardial infarction.
  • Myocardial infarction can lead to contractile dysfunction, ventricular remodeling, and heart failure.
  • Cell transplantation is a therapeutic strategy explored for cardiac repair.

Purpose of the Study:

  • To evaluate the efficacy of different cell types for myocardial repair.
  • To investigate cell therapy outcomes based on cardiac pathology and cell type.
  • To determine the most effective cell source for specific cardiac conditions.

Main Methods:

  • Review of studies on cell transplantation in myocardial infarction models.
  • Analysis of functional benefits of bone marrow cells in hibernating myocardium.
  • Assessment of skeletal myoblast implantation for contractile dysfunction.

Main Results:

  • Bone marrow cells offer functional benefits for hibernating myocardium but do not resolve transmural fibrosis.
  • Skeletal myoblasts demonstrate efficacy in treating the underlying cause of disease: loss of cell contractility.
  • Cell therapy effectiveness is contingent on the specific cell type and cardiac pathology.

Conclusions:

  • Cell type selection is critical for successful cardiac repair after myocardial infarction.
  • Skeletal myoblasts are a viable option for restoring contractility in damaged myocardium.
  • Further research is needed to optimize cell-based therapies for heart failure treatment.

Keywords:
CardiomyopathyCell transplantationSkeletal myoblastsStem cells

More Related Videos

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.08:37

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.

Published on: March 3, 2021

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...